Many people still judge menopause hormone therapy by outdated headlines. Current guidance is more nuanced: decisions depend on symptom burden, age, time since menopause and personal risk history. A personalised plan tells you more than any one-size-fits-all message.
Myth: everyone has the same risk
Risk differs with formulation, route, dose and patient history. Transdermal options may be preferred when cardiovascular risk is a concern, while the choice of progestogen can change how well therapy is tolerated. Absolute risk, not just relative risk, belongs in the discussion.
Myth: hormones are only for hot flashes
Vasomotor symptoms are common, but conversations about therapy may also cover disrupted sleep, mood changes, genitourinary symptoms and the effect on quality of life. Local therapies may be considered when symptoms are mainly urogenital.
Myth: once started, therapy cannot be changed
Menopause care is dynamic. Clinicians can adjust dose, change route, reassess duration or move to non-hormonal strategies as your priorities shift. Regular follow-up makes treatment a tailored long-term plan rather than a fixed protocol.
Myth: hormone therapy always causes breast cancer
The truth is more nuanced. Combined estrogen-and-progestogen therapy is linked to a small rise in breast cancer risk with longer use, roughly comparable in size to the effect of drinking alcohol regularly or being overweight. Estrogen alone, used by women who have had a hysterectomy, has not shown the same increase, and some long-term data suggest a possible reduction. Routine screening mammograms matter whichever treatment you choose.
Myth: always take the lowest dose for the shortest time
Older guidance advised limiting treatment to a set number of years. Current recommendations are more flexible: the right dose and duration depend on your symptoms, age and risk profile and should be reviewed at least once a year. Some women do well stopping after a few years, while others continue because symptoms return or they want the bone protection. Neither is wrong, and stopping gradually is often easier than stopping abruptly.
Myth: bioidentical means safer
Bioidentical hormones are chemically identical to those in the body, and several approved products are bioidentical. The label alone does not make a product safer, and custom-compounded versions have not been shown to beat approved ones. Our bioidentical hormone guide explains how to tell approved from compounded products.
Myth: you have to wait until your periods stop
You can discuss treatment during perimenopause, when symptoms are often at their worst. Dosing may need more adjustment while your own hormones are still fluctuating, but waiting is not required. Starting earlier in the transition is linked to the most favourable balance of benefits and risks.
How to separate good advice from bad
Check whether the source cites current guidelines, such as those from the Menopause Society, and whether it discusses both benefits and risks. Be wary of absolute words like "always" or "never", of anyone selling something alongside the advice, and of claims that doctors are hiding the truth. A sound source says what is known, what is uncertain and when to seek individual advice. Our article on the WHI study shows how headline findings can mislead.
Myth: hormone therapy is only for severe symptoms
Severity matters, but it is not the only reason women choose treatment. Some start because of lost sleep, vaginal discomfort or worry about bone health, even when hot flashes are mild. Others find that once symptoms are controlled they feel more like themselves at work and at home. The right question is how much your symptoms affect your quality of life, not whether they pass some threshold of suffering.
Myth: non-hormonal options do not work
For women who cannot or prefer not to use hormones, several evidence-based alternatives exist. Fezolinetant, a newer non-hormonal medicine, targets the brain pathway behind hot flashes. Low-dose paroxetine, venlafaxine and gabapentin reduce hot flashes by a meaningful amount for many women, though less than estrogen does. Cognitive behavioural therapy helps with how bothersome symptoms feel and with sleep. Discuss these openly, since the best plan is sometimes a combination.
Myth: you will gain weight on HRT
Studies have not shown that hormone therapy causes weight gain. Weight creeps up in midlife because of age, lost muscle, poor sleep and lower activity. What falling estrogen does change is where fat is stored, moving it towards the waist. Therapy may help blunt that shift, but it is not a weight-loss treatment. Our menopausal weight gain guide explains what does help.
Myth: telehealth HRT is not real medical care
A properly run telehealth service involves a licensed clinician who reviews your history, orders any needed tests, prescribes within medical guidelines and follows up. That is the same clinical process as an office visit, delivered remotely. What separates good from poor telehealth is the quality of screening and follow-up, which is why our provider checklist focuses on those questions.
What to remember
Hormone therapy is a medical treatment with real benefits and real, mostly small, risks, and the right choice varies from woman to woman. Be sceptical of anyone who calls it either miraculous or dangerous in all cases. Take your questions and your history to a qualified clinician and revisit the decision regularly.